Cite
HARVARD Citation
Hoffman, R. et al. (2017). Gene Expression and Pharmacodynamic Changes in 1, 760 Systemic Lupus Erythematosus Patients From Two Phase III Trials of BAFF Blockade With Tabalumab. Arthritis & rheumatology. 69 (3), pp. 643-654. [Online].